drugset / Trial / NCT00450242

5% Lidocaine Ointment in the Treatment of Vulvar Vestibulitis

NCT00450242

Phase 2 Terminated 14 enrolled University of North Carolina, Chapel Hill
RandomizedSingle-groupDouble-blindTreatment

Summary

* Study Hypothesis: Use of 5% topical lidocaine ointment will result in improved ability to have sexual intercourse and decreased pain scores in women with vestibulitis when compared to placebo. * This is a study to assess if topical lidocaine will improve symptoms in women with vulvar vestibulitis. It compares use of nightly 5% topical lidocaine ointment to placebo ointment. The duration of the study is 8 weeks. 28 women will be in each arm for a total of 56 women in the study.

Timeline

Start
2006-12
Primary completion
2009-01
Completion
2009-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Lidocaine Other / unclassified 5 % Topical

Indications